Structure and function of the mammalian fibrillin gene family: Implications for human connective tissue diseases
Abstract
Fibrillins and latent transforming growth factor β binding proteins (LTBPs) are components of the extracellular matrix of connective tissue. While fibrillins are integral to the 10nm microfibrils, and often associated with elastin, all family members are likely to have an additional role in regulating the bioavailability of transforming growth factor β (TGBβ). Both fibrillins and LTBPs are large glycoproteins, containing a series of calcium binding epidermal growth factor domains as well as a number of copies of a unique 8 cysteine domain found only in this protein superfamily. There are three mammalian fibrillins and four LTBPs. Fibrillin monomers link head to tail in microfibrils which can then form two and three dimensional structures. In some tissues elastin is recruited to the fibrillin microfibrils to provide elasticity to the tissue. LTBPs are part of the TGBβ large latent complex which sequesters TGBβ in the extracellular matrix. Fibrillin-1 appears to bind to LTBPs to assist in this process and is thus involved in regulating the bioavailability of TGBβ. Mutation of fibrillin genes results in connective tissue phenotypes which reflect both the increased level of active TGBβ and the structural failure of the extracellular matrix due to the absence or abnormality of fibrillin protein. Fibrillinopathies include Marfan syndrome, familial ectopia lentis, familial thoracic aneurysm (mutations of FBN1) and congenital contractural arachnodactyly (mutation of FBN2). There are no diseases currently associated with mutation of FBN3 in humans, and this gene is no longer active in rodents. Expression patterns of fibrillin genes are consistent with their role in extracellular matrix structure of connective tissue. FBN1 expression is high in most cell types of mesenchymal origin, particularly bone. Human and mouse FBN2 expression is high in fetal cells and has more restricted expression in mesenchymal cell types postnatally. FBN3 is expressed early in development (embryonic and fetal tissues) in humans. The fibrillins are thus important in maintaining the structure and integrity of the extracellular matrix and, in combination with their sequence family members the LTBPs, also contribute to the regulation of the TGFβ family of major growth factors.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fibrillin-2 interacts directly with fibrillin-1, EMILIN-1, and LTBPs to regulate the bioavailability of TGFβ.
“Besides, fibrillin-2 interacts directly with fibrillin-1, EMILIN-1, and LTBPs to regulate the bioavailability of TGFβ, a growth factor and key regulator of connective tissue organization and blood vessels development and maintenance [27,29].”
The citation lists haven’t been fetched yet
References 122 · Cited by 103
- Authors
- Davis, M. R., & Summers, K. M.
- Affiliations
- Roslin Institute (GB)
- Corresponding author
- Summers, Kim M.
- ORCID
- Summers, Kim M.
- Venue
- Molecular Genetics and Metabolism
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 107
- Issue
- 4
- Pages
- 635-647
- ISSN
- 1096-7192 (ISSN-L)
- OpenAlex
- W2057517302
- Cited by
- 103
- References
- 122
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 8 · 2023: 7 · 2022: 8 · 2021: 6 · 2020: 11 · 2019: 5 · 2018: 7 · 2017: 4 · 2016: 14 · 2015: 5 · 2014: 12 · 2013: 7 · 2012: 1
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Genetics and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Biotechnology and Biological Sciences Research Council (BBS/E/D/20211553, BBS/E/D/20221657)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- fibrillin-1, fibrillin-2, extracellular matrix, microfibrils, elastin, connective tissue diseases, Marfan syndrome, congenital contractural arachnodactyly, fibrillinopathies, gene expression patterns, epidermal growth factor domain
- MeSH terms
- Fibrillins, Fibrillin-1, Fibrillin-2, Animals, Connective Tissue Diseases, Multigene Family, Humans, Microfilament Proteins, Mutation, Latent TGF-beta Binding Proteins, Adipokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review